Director, Chief Medical Officer · Evommune, Inc. · Evommune, Inc. — Employee Stock Option (Right to Buy)
Side
A
Value
—
Shares
100.0K
Price
—
Executed
Dec 8, 2025
Disclosed
Dec 19, 2025
Disclosure timeline11 days from execution to publication · legal deadline 2 business days
Dec 8 executedDec 19, 2025 disclosed
EVMN · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+10 / 15
Disclosed 9 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Evommune, Inc. — Employee Stock Option (Right to Buy)
Ticker
EVMN
Shares
100.0K
Price per share
$0
Execution date (reported)
Dec 8, 2025
Owned after transaction
100.0K shares
Days from execution to publication
11
What this establishes
Bauer Eugene filed this Form 4 reporting a grant or award of EVMN on Dec 8, 2025. It became public on Dec 19, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Medical Officer
Bauer Eugenecik:0001678620
Issuer
Evommune, Inc.cik:0002044725
Revision history · 0
No field has changed since this record was first ingested.
